In addition, we were not able to specifically assess the degree of eNOS modification with O‐GlcNAc in endothelial cells from patients with T2DM because the number of cells obtained was too small to permit immunoprecipitation of eNOS alone. The gene discussed is NOS3; the disease is type 2 diabetes mellitus.